Diffuse malignant mesothelioma: a review.
Diffuse malignant mesothelioma is a signal tumor of asbestos exposure. Mesothelioma incidence has been steadily rising during the past two decades, reflecting the increases in asbestos use during and following World War II. The onset of the disease follows exposure by 25 to 40 years. The dose-response relationship appears to be much lower than that for asbestosis or lung cancer-it is not known whether current levels of exposure will entail a risk for disease 30 years hence. There is no synergistic or additive interaction with smoking for this tumor. Current knowledge indicates that pleural plaques, per se, do not increase the risk for this tumor beyond that of the previous asbestos exposure alone. Durable fibers with high aspect ratios, especially amphiboles, are associated with experimental tumor induction. Treatment modalities including surgical procedures and chemotherapy with doxorubicin and 5-azacytidine offer prospects for palliation.
D000818:Animals; D001195:Asbestosis / Q000150:complications*; D006801:Humans; D008654:Mesothelioma / Q000175:diagnosis / Q000209:etiology*; D009784:Occupational Diseases / Q000209:etiology*; D009790:Occupations; D010997:Pleural Neoplasms / Q000175:diagnosis / Q000209:etiology*; D012306:Risk